Correlation between bone metastasis and thrombocytosis in pulmonary adenocarcinoma patients
Authors:
Open Access
- 4 December 2014
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 9 (2) , 762-768
Abstract
Thrombocytosis is commonly observed in patients exhibiting a variety of malignancies, including pulmonary, gastrointestinal and hepatic cancer. In the present study, the correlation between distant metastasis and thrombocytosis was retrospectively reviewed in 308 cases of histopathologically confirmed pulmonary adenocarcinoma. The patients were classified as having thrombocytosis or not, based on their platelet counts upon diagnosis; thrombocytosis was documented in 82/308 patients (26.6%). A log‑rank test indicated a statistically significant difference in survival between patients exhibiting thrombocytosis compared with patients not exhibiting thrombocytosis (P<0.001). In addition, the occurrence of distant metastasis and the survival period were correlated with the presence of thrombocytosis upon diagnosis. In descending order of frequency, metastases were documented at the following sites: Lymph nodes (218/308 patients; 70.8%), bone (138/308 patients; 44.8%), lung (93/308 patients; 30.2%), brain (67/308 patients; 21.8%), liver (46/308 patients; 4.9%), adrenal glands (11/308 patients; 3.6%) and kidneys (5/308 patients; 1.6%). Bone metastasis occurred significantly more frequently in patients exhibiting thrombocytosis (50/82 patients: 61.0%; P<0.05) compared with patients not exhibiting thrombocytosis (88/226 patients; 38.9%). Furthermore, according to univariate analysis, thrombocytosis, weight loss, an Eastern Cooperative Oncology Group performance status score of ≥2 points, anemia, increased erythrocyte sedimentation rate, and increased alkaline phosphatase (AKP) and carcinoembryonic protein (CEA) levels were risk factors for bone metastasis. According to multivariate analysis, thrombocytosis, weight loss, and increased AKP and CEA levels were correlated with bone metastasis. Therefore, patients exhibiting pulmonary adenocarcinoma and thrombocytosis have a higher risk of bone metastasis compared with patients not exhibiting thrombocytosis.Keywords
This publication has 33 references indexed in Scilit:
- Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancerEuropean Journal of Surgical Oncology, 2012
- Prognostic impact of thrombocytosis in resectable non-small cell lung cancerInteractive CardioVascular and Thoracic Surgery, 2008
- Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungsOncogene, 2007
- Preoperative thrombocytosis predicts poor survival in patients with glioblastomaNeuro-Oncology, 2007
- Prognosis of Breast Cancer After Supraclavicular Lymph Node Metastasis: Not a Distant MetastasisAnnals of Surgical Oncology, 2006
- Androgen Mediation of Thrombocytosis in Epithelial Ovarian Cancer BiologyClinical Cancer Research, 2005
- The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinomaCancer, 2004
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- ThrombocytosisNew England Journal of Medicine, 2004
- Thrombopoietin: The Primary Regulator of Platelet ProductionTrends in Endocrinology & Metabolism, 1997